TNF and non-small cell lung carcinoma: Curcumol was found to overcome tumour necrosis factor(TNF)-related apoptosis-inducing ligand (TRAIL) resistance of non-small cell lung cancer (NSCLC), and NQO2 was identified as an important curcumol target, binding with a Kd of 0.58 μM [42].